GLPro Official Website › Guides › Blood sugar supplement guide
Blood Sugar Supplements: What the Evidence Says and What It Does Not
Most blood sugar supplements rest on small trials of a few ingredients: berberine, cinnamon, chromium, gymnema and soluble fibre. Berberine and psyllium have the most consistent pooled results, cinnamon and chromium are mixed, and none matches a structured lifestyle programme or a prescribed medicine. Diabetes guidelines do not generally recommend supplements for blood sugar without a deficiency.
Written for somebody who may never buy anything here. Numbers first, then ingredients, then risks.
Blood sugar, insulin resistance, prediabetes and A1C
Blood sugar is the glucose in your blood. It rises after a meal, and insulin, a hormone from the pancreas, moves it into muscle, fat and liver cells. In insulin resistance those cells respond less well, so the pancreas makes more insulin to keep up; when it cannot, blood sugar drifts above normal. The NIDDK explains the process.
Prediabetes is the stage in between: above normal, not yet type 2 diabetes. The CDC estimates that more than two in five American adults have it, and about eight in ten of them do not know. The CDC’s diabetes basics describe the main types; type 2, the one linked to insulin resistance, accounts for most cases.
A1C measures how much glucose has attached to haemoglobin in red blood cells, which reflects the average over roughly three months, as MedlinePlus explains. Because it is an average it moves slowly, so a product said to change it within weeks claims more than the test can show.
| Test | Normal | Prediabetes | Diabetes |
|---|---|---|---|
| A1C | Below 5.7% | 5.7% to 6.4% | 6.5% or higher |
| Fasting plasma glucose | Below 100 mg/dL | 100 to 125 mg/dL | 126 mg/dL or higher |
| Two-hour glucose tolerance test | Below 140 mg/dL | 140 to 199 mg/dL | 200 mg/dL or higher |
One result is not a diagnosis. Abnormal tests are usually repeated, anaemia can make A1C less reliable, and a home meter is for monitoring, not diagnosis.
What actually moves the numbers
The strongest evidence here is not about a capsule. In the Diabetes Prevention Program trial, 3,234 adults with raised glucose were assigned to an intensive lifestyle programme, metformin or placebo. The lifestyle group, aiming for 7% weight loss and 150 minutes of activity a week, developed type 2 diabetes 58% less often than placebo over an average of 2.8 years. Metformin cut the rate by 31%.
The American Diabetes Association’s 2025 Standards of Care put nutrition, activity, sleep and psychosocial care at the centre. They state that there is no clear evidence that vitamins, minerals, herbs or spices improve outcomes in people with diabetes who have no deficiency, and that they are not generally recommended for glucose control.
A structured programme
Coached changes to food and activity. The best-tested way to delay type 2 diabetes.
Prescribed medicine
Metformin, GLP-1 medicines and others, dosed and monitored by a clinician.
A supplement
Small trials and no guideline endorsement. At most an addition to the first two.
The ingredients sold most often, and the evidence on each
Six ingredients recur on blood sugar labels. The table grades the research on each ingredient, not on any product.
GLPro, the capsule this website sells, publishes no formula, so it does not say whether it contains any of these. Its ingredients page explains the gap.
| Ingredient | What the research found | Strength | Main caution |
|---|---|---|---|
| Berberine | Meta-analyses of trials in type 2 diabetes report lower fasting glucose and A1C (Guo 2021; Dong 2012). Most trials were small. | Moderate, from limited-quality trials | Stomach upset; may interact with medicines (NCCIH) |
| Cinnamon | Allen 2013: a statistically significant fall in fasting glucose, no significant A1C change. Costello 2016 found the trials inconsistent, partly because preparations differed. | Weak, mixed | Cassia contains coumarin, which in large amounts can harm the liver (NCCIH) |
| Chromium | Suksomboon 2014: modest gains on some measures, varying by form and dose. The NIH fact sheet calls the results mixed. | Weak, mixed | May add to diabetes medicines |
| Gymnema | Devangan 2021 pooled a few trials reporting lower fasting glucose and A1C. | Limited: few, small trials | May add to diabetes medicines |
| Psyllium (soluble fibre) | Gibb 2015: better fasting glucose and A1C in type 2 diabetes and at-risk groups, growing with how high glucose was. Little effect at normal glucose. | Moderate, consistent | Needs several grams a day with water; bloating at first |
| Glucomannan (fibre) | Sold for fullness. Onakpoya 2014 found no significant weight loss across the trials it pooled. | Weak | Swells, so it is taken with plenty of fluid |
Every trial here gave a named ingredient at a stated dose. A product that prints neither, or prints far less, cannot borrow the result. Our longer article on these ingredients gives each one more room.
Before trusting a study quoted on a supplement page, ask:
- ✓Who took part? A result in type 2 diabetes may not apply at normal glucose, as psyllium shows.
- ✓How long did it run? A few weeks is short for A1C, which reflects three months.
- ✓What was the comparison? Placebo, another drug and nothing at all give different answers.
Safety and interactions, the part labels print smallest
Anything that changes blood sugar can also interact with the medicines people with raised blood sugar take. Two risks stand out.
Low blood sugar
Insulin and sulfonylureas can push glucose too low on their own, and a supplement that lowers glucose could add to it. The NIDDK lists the signs, including shakiness, sweating and confusion, and treats a level below 70 mg/dL as low.
Slower drug clearance
In healthy volunteers, two weeks of berberine slowed several liver enzymes that break down common medicines (Guo 2012). A drug cleared more slowly builds up.
NCCIH advises never replacing proven treatment with an unproven product, and telling every clinician what you take. Our article on supplements and diabetes medication covers the common combinations.
If you take insulin or a sulfonylurea, start no blood sugar supplement until your prescriber has seen the bottle. If you are pregnant, nursing or under 18, leave the category alone.
GLP-1 medicines, and supplements that borrow the language
GLP-1 is a gut hormone released after eating. It prompts insulin release when glucose is high, slows stomach emptying and reduces appetite (Drucker 2018). The body breaks its own GLP-1 down within minutes, so the medicines are engineered to last far longer.
Semaglutide and tirzepatide are prescription medicines built on that system. In the STEP 1 trial, 1,961 adults with overweight or obesity took weekly semaglutide or placebo with lifestyle support for 68 weeks, and average weight fell 14.9% against 2.4%.
| Question | GLP-1 medicine | Supplement using GLP-1 wording |
|---|---|---|
| Regulated as | A prescription drug, FDA-approved for set uses | A dietary supplement; none is FDA-approved |
| Evidence | Large trials of the exact product and dose | At best, single-ingredient studies |
| Claims allowed | Treatment of a named condition | Normal body function only |
Research on raising the body’s own GLP-1 through food is real: a 2026 scoping review mapped studies of dietary fibres and GLP-1 release. Mapping studies is not the same as showing that a capsule acts like a medicine. The FDA has also warned about unapproved and counterfeit GLP-1 drugs sold online.
GLPro, the capsule this website sells, is not a GLP-1 medication and does not replace one, although one label version prints “Natural GLP-1 Booster”. Our article on the name explains why this desk does not repeat that phrase.
How to talk to a clinician about a supplement
Five minutes with a pharmacist or doctor does more than any amount of label reading.
Bring the bottle
Not a photo of the front. The panel on the back is what a pharmacist needs.
Bring your numbers
Your latest A1C or fasting glucose, with its date, and why you are asking.
List everything you take
Prescriptions, over-the-counter medicines and other supplements.
Ask two questions
Could this push my glucose too low with what I take? Could it change how my other medicines are cleared?
Agree a date to check back
A repeat A1C after about three months is a fair test of anything that claims to help.
If a clinician says no, that outranks any refund window. Our ten-point checklist covers questions for the product itself, and the safety page applies them to this desk’s capsule.
Who wrote this guide, and how it was checked
This desk publishes what the bottle says and marks the gaps. The four claims below are the ones a sceptical reader can audit in ten minutes, which is the only reason to make them:
- The bottle is the source. The two claim lines, the capsule count and the supply length come from the printed label and the seller’s own artwork. Prices come from the seller’s order page, not from a review column.
- The gaps are marked, never filled in. The seller names no ingredient and prints no amount, so this website names none and estimates none, including in the structured data a search engine reads.
- Sources are real and linked in the sentence. Every study cited here was confirmed against its PubMed record before it was written down, and every government page was opened and checked by its title rather than assumed.
- Corrections change the date. Write to [email protected] and the review date at the foot of the page moves forward.
We earn when you buy. Glprodaily is the USA Authorized GLPro Retailer named at the top of this page, and this website makes money on orders placed through it. That is exactly why the missing-formula notes, the three-star review and the plain statement that GLPro is not a GLP-1 medication are here: they are where our interest and yours pull apart, and you should be able to watch us choose.
Order support on +1 (302) 200-3480 and [email protected] handles tracking, changes, cancellations and refunds. It is not a sales line, and this website never presents it as a way to place an order: orders go through the checkout only.
About this guide. It grades a category, not a product.
Sources cited in this guide
- National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Resistance & Prediabetes. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
- Centers for Disease Control and Prevention. Prediabetes: Your Chance to Prevent Type 2 Diabetes. https://www.cdc.gov/diabetes/prevention-type-2/prediabetes-prevent-type-2.html
- Centers for Disease Control and Prevention. Diabetes Basics. https://www.cdc.gov/diabetes/about/index.html
- MedlinePlus, U.S. National Library of Medicine. Hemoglobin A1C (HbA1c) Test. https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/
- American Diabetes Association Professional Practice Committee. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S86-S127. https://pubmed.ncbi.nlm.nih.gov/39651983/
- Guo J, Chen H, Zhang X, et al. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev. 2021;2021:2074610. https://pubmed.ncbi.nlm.nih.gov/34956436/
- Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012;2012:591654. https://pubmed.ncbi.nlm.nih.gov/23118793/
- National Center for Complementary and Integrative Health. Berberine and Weight Loss: What You Need To Know. https://www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know
- Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med. 2013;11(5):452-9. https://pubmed.ncbi.nlm.nih.gov/24019277/
- Costello RB, Dwyer JT, Saldanha L, et al. Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review. J Acad Nutr Diet. 2016;116(11):1794-1802. https://pubmed.ncbi.nlm.nih.gov/27618575/
- National Center for Complementary and Integrative Health. Cinnamon: Usefulness and Safety. https://www.nccih.nih.gov/health/cinnamon
- Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014;39(3):292-306. https://pubmed.ncbi.nlm.nih.gov/24635480/
- NIH Office of Dietary Supplements. Chromium: Fact Sheet for Consumers. https://ods.od.nih.gov/factsheets/Chromium-Consumer/
- Devangan S, Varghese B, Johny E, et al. The effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Phytother Res. 2021;35(12):6802-6812. https://pubmed.ncbi.nlm.nih.gov/34467577/
- Gibb RD, McRorie JW Jr, Russell DA, Hasselblad V, D'Alessio DA. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr. 2015;102(6):1604-14. https://pubmed.ncbi.nlm.nih.gov/26561625/
- Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. J Am Coll Nutr. 2014;33(1):70-8. https://pubmed.ncbi.nlm.nih.gov/24533610/
- National Institute of Diabetes and Digestive and Kidney Diseases. Low Blood Glucose (Hypoglycemia). https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia
- Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-7. https://pubmed.ncbi.nlm.nih.gov/21870106/
- National Center for Complementary and Integrative Health. Diabetes and Dietary Supplements: What You Need To Know. https://www.nccih.nih.gov/health/diabetes-and-dietary-supplements-what-you-need-to-know
- Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metab. 2018;27(4):740-756. https://pubmed.ncbi.nlm.nih.gov/29617641/
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- de Jong JCBC, et al. Dietary fibers to boost endogenous GLP-1 secretion and satiety: a scoping review. Front Endocrinol (Lausanne). 2026;17:1880500. https://pubmed.ncbi.nlm.nih.gov/42528510/
- U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. JAMA Netw Open. 2018;1(6):e183337. https://pubmed.ncbi.nlm.nih.gov/30646238/
- U.S. Food and Drug Administration. Health Fraud Scams. https://www.fda.gov/consumers/health-fraud-scams